IRVINE, CA / ACCESSWIRE / July 14, 2017 / Khang & Khang LLP (the "Firm") announces a securities class action lawsuit against Neurotrope, Inc. ("Neurotrope" or the "Company") (NTRP). Investors who purchased or otherwise acquired Neurotrope shares from January 7, 2016 through April 28, 2017, inclusive (the "Class Period"), are encouraged to contact the Firm before the July 17, 2017 lead plaintiff motion deadline.

If you purchased Neurotrope shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet, and until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.

According to the Complaint, throughout the Class Period, Neurotrope made false and/or misleading statements and/or failed to disclose material adverse information about the efficacy of its lead product candidate, Bryostatin-1. On May 1, 2017, the Company announced "positive top-line results" for the focal Phase 2b trials of Bryostatin-1, mentioning "improvement in patients with moderate to severe Alzheimer's disease." The trial data refutes these statements, however, as the top-line data relating to the 20-microgram dose of Bryostatin-1 did not produce statistically significant results. Neurotrope also allegedly failed to disclose statements about the efficacy of the 40-microgram dose in connection with its primary and secondary endpoints. After release of this news, the stock price of Neurotrope fell materially, which harmed investors according to the Complaint.

If you want to learn more about this lawsuit, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for nearly two decades, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contact

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP